Annual Gala | Company’s 2023 “Accumulate Strength, Seize the Momentum” Annual Meeting Unveils a Spectacular Show

Usher in a new era, take new steps, write a new chapter, and achieve new accomplishments.

On January 12, Weiboxin successfully held “ Accumulate steadily and unleash power; seize the momentum and forge ahead. The 2023 Annual Gala and Awards Ceremony, themed “...,” was held. Chairman Xu Guifeng, together with all employees, reviewed the outstanding achievements of the past year, recognized individuals and teams who made exceptional contributions, and united as one to kick off the passionate journey ahead in 2024. 
 

Host’s Opening Remarks for the Annual Meeting

“Uphold our original aspiration with steadfast action and unwavering diligence, and forge ahead with vigor to embark on a new journey.” Mr. Xu Guifeng, Chairman of Weiboxin, delivered a New Year greeting. In his address, he began by extending heartfelt gratitude to both new and longstanding customers, friends from all sectors of society, and the company’s dedicated employees. He then reviewed the company’s more than decade-long journey of pioneering and progressive development, outlined an optimistic outlook for high-quality growth, underscored the importance of sustained corporate development, and urged everyone to keep the company’s mission firmly in mind and faithfully uphold it. Quality and service are the foundation of our success. , laying a solid foundation for the sustainable development of the enterprise.

On this new journey, he called on every member to forge ahead with courage, continue to deepen our market penetration, hold ourselves to the highest standards, and demonstrate Weiboxin’s strength and sense of responsibility.

Finally, I wish everyone good health, success in all endeavors, and happiness for the whole family in the New Year!

In 2024, our sole goal is to embody the timeless motto: “Just do it!” Throughout the year, every single employee at Weiboxin Biotechnology will give it our all. As the saying goes, “The pass may be steep and rugged, yet it is as solid as iron—now we take a bold step forward and surmount it once more.” By the end of 2024, let’s take stock of each and every one of you here today: how have you performed, and what contributions have you made? Let us work together, strive with unwavering determination, and earn the glory that belongs to each of us, to our team, and to this company!

“When everyone unites as one, and a thousand hearts beat as one, we can harness the strength of a thousand.” Weiboxin’s achievements today are the result of the tenacious efforts and selfless dedication of every member of the Weiboxin family. Weiboxin honored the teams and individuals who delivered outstanding performance in 2023.

With the awards ceremony and raffle now concluded, the company had meticulously planned a lavish gala dinner accompanied by an array of captivating performances. A diverse lineup of talent shows took center stage, featuring heartfelt yet youthful songs, electrifying dances, witty skits, and lively “three-sentence-and-a-half” acts—each showcasing the unique talents and creativity of our colleagues across departments and adding vibrant flair to the evening.

Opening Dance: “Do You Want to Dance?”

The finale: "A Heart of Gratitude"

Finally, there is a song called “A Heart of Gratitude.”

To all our new and existing customers,

Friends from all sectors of society and

To all our hardworking employees.

Paint a splendid tapestry to bid farewell to the old year, and celebrate the New Year with refined elegance! 
 

In 2023, Weiboxin has delivered a flawless performance.

Yet the pursuit of our dreams has never ceased.

In the new year, we will

Soar on the wings of our dreams to pioneer the future, and forge ahead with unwavering determination to make our dreams a reality!

Accumulate steadily and unleash power; seize the momentum and forge ahead.

Looking back on 2023, the people of Weiboxin have embraced the tide by riding the waves, upheld the banner and led the way while keeping a vigilant eye on the storms, walked hand in hand across mountains and seas, and welcomed the sunshine after weathering countless trials. 
 

Looking ahead to 2024, all members of Weiboxin will, guided by the goal of “comprehensive value leadership,” stay true to our original aspiration, forge ahead with unwavering determination, and strive toward “ Becoming the preferred supplier of animal disease and pet diagnostic reagents accelerating progress toward the strategic goal of “”.

Finally, we would like to extend our heartfelt gratitude to all the planners and staff—both on and off stage—who made this annual gala a resounding success, giving us an unforgettable experience on life’s journey.

When looking for animal disease and pet diagnostic reagents, choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-66377266 / 135 3988 6748, Ms. Dai

Guangzhou Weiboxin Biotechnology Co., Ltd. is located in the national-level innovation park—Guangzhou Science City. The company is a provincial-level “Little Giant” high-tech enterprise specializing in the forward R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. It has been recognized as a “Contract-Honoring and Credit-Keeping Enterprise” by Guangdong Province and as a provincial demonstration unit for intellectual property. Additionally, it serves as an industry–university–research collaboration base for Guangdong Food and Drug Vocational College and as an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. The company has been designated as an innovative, high-potential enterprise by multiple research institutions, including the Entrepreneurship College of Jinan University in Guangdong Province, and has been awarded the titles of “Specialized, Refined, Distinctive, and Innovative” enterprise at both municipal and provincial levels. It has also received the “Most Investment-Valuable Enterprise” award and the annual title of “ASF and Swine Disease Testing Service Provider.” Furthermore, its veterinary drug product has been granted an approval number by the Ministry of Agriculture and Rural Affairs—Veterinary Drug Production No. 191438923 (African Swine Fever Virus Fluorescent PCR Diagnostic Kit). The company won the Excellence Award in the Growth Category of the Biopharmaceutical Industry at the 11th China Innovation and Entrepreneurship Competition, secured the Provincial Second Prize in the Growth Category of the Nanotechnology Industry Technology Competition, and earned the National Third Prize in the Growth Category of the National Finals of the Nanotechnology Industry Technology Innovation Special Competition within the China Innovation and Entrepreneurship Competition. It has consecutively received the A-Level Tax Credit Honor Certificate, the Four-Star Trademark and Brand Certification, and the Two-Integration Management System Assessment Certificate each year. In addition, it holds ISO 9001 International Quality Management System Certification, ISO 14001 International Environmental Management System Certification, and GMP certification from the Ministry of Agriculture. Since its establishment, the company has been granted a total of 24 patents, including 5 invention patents, 15 utility model patents, and 4 design patents, along with 4 registered trademarks.

The company boasts robust technical capabilities and a team of world-class professionals, including dozens of masters, doctors, and returnees who studied abroad, as well as numerous senior-title technical experts. Currently, the company’s primary focus is on the research and development of molecular diagnostic reagents. Its core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, including public-health–oriented fluorescent PCR test kits, animal disease–control–oriented fluorescent PCR test kits, clinical and research–grade fluorescent quantitative PCR kits, and transgenic identification test kits (ZL2006). The company has also established a nationwide distribution network covering over ten major cities, such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao.

Looking ahead, Weiboxin will remain steadfast in its commitment to continuously enhance product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, we will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advancing life sciences. Quality is our lifeline; innovation is our soul. Upholding this guiding principle, we will relentlessly strive to become the premier supplier of rapid diagnostic reagents and instruments.